Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 457

1.
2.

The Evaluation of the Effectiveness of Austrians Disease Management Program in Patients with Type 2 Diabetes Mellitus - A Population-Based Retrospective Cohort Study.

Riedl R, Robausch M, Berghold A.

PLoS One. 2016 Aug 17;11(8):e0161429. doi: 10.1371/journal.pone.0161429. eCollection 2016.

3.

The benefit and efficiency of the disease management program for type 2 diabetes.

Linder R, Ahrens S, Köppel D, Heilmann T, Verheyen F.

Dtsch Arztebl Int. 2011 Mar;108(10):155-62. doi: 10.3238/arztebl.2011.0155. Epub 2011 Mar 11.

4.
5.
6.

Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes.

Schäfer I, Küver C, Gedrose B, von Leitner EC, Treszl A, Wegscheider K, van den Bussche H, Kaduszkiewicz H.

BMC Health Serv Res. 2010 Dec 31;10:351. doi: 10.1186/1472-6963-10-351.

7.

Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment.

Burke J, Kovacs B, Borton L, Sander S.

Postgrad Med. 2012 Mar;124(2):77-91. doi: 10.3810/pgm.2012.03.2539.

PMID:
22437218
8.

Health care resource utilization associated with a diabetes center and a general medicine clinic.

Huang ES, Gleason S, Gaudette R, Cagliero E, Murphy-Sheehy P, Nathan DM, Singer DE, Meigs JB.

J Gen Intern Med. 2004 Jan;19(1):28-35.

9.

Continuity of ambulatory care and health outcomes in adult patients with type 2 diabetes in Korea.

Hong JS, Kang HC.

Health Policy. 2013 Feb;109(2):158-65. doi: 10.1016/j.healthpol.2012.09.009. Epub 2012 Oct 23.

PMID:
23093021
10.

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.

Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.

Clin Ther. 2009 Nov;31(11):2653-64. doi: 10.1016/j.clinthera.2009.11.032.

PMID:
20110008
11.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.

PMID:
18036392
12.

Systemwide provider performance in a Medicaid program. Profiling the care of patients with chronic illnesses.

Powe NR, Weiner JP, Starfield B, Stuart M, Baker A, Steinwachs DM.

Med Care. 1996 Aug;34(8):798-810.

PMID:
8709661
13.

The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences.

Schäfer I, Küver C, Gedrose B, Hoffmann F, Russ-Thiel B, Brose HP, van den Bussche H, Kaduszkiewicz H.

BMC Health Serv Res. 2010 Mar 3;10:55. doi: 10.1186/1472-6963-10-55.

14.

Medical costs of managed care in patients with type 2 diabetes mellitus.

Bhattacharyya SK, Else BA.

Clin Ther. 1999 Dec;21(12):2131-42.

PMID:
10645758
15.
16.

Supply sensitive services in Swiss ambulatory care: an analysis of basic health insurance records for 2003-2007.

Busato A, Matter P, Künzi B, Goodman DC.

BMC Health Serv Res. 2010 Nov 23;10:315. doi: 10.1186/1472-6963-10-315.

17.

[Cost evaluation of a model for integrated care of seriously mentally ill patients].

Fischer F, Hoffmann K, Mönter N, Walle M, Beneke R, Negenborn S, Weinmann S, Willich SN, Berghöfer A.

Gesundheitswesen. 2014 Feb;76(2):86-95. doi: 10.1055/s-0033-1343438. Epub 2013 Jun 4. German.

PMID:
23737155
18.

Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.

Berman S, Rannie M, Moore L, Elias E, Dryer LJ, Jones MD Jr.

Pediatrics. 2005 Jun;115(6):e637-42.

PMID:
15930189
19.

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Olivares JM, Rodriguez-Martinez A, Burón JA, Alonso-Escolano D, Rodriguez-Morales A; e-STAR Study Group.

Appl Health Econ Health Policy. 2008;6(1):41-53.

PMID:
18774869

Supplemental Content

Support Center